Citations (27)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Ryan T Hurt, Manpreet S Mundi & Jon O Ebbert. (2018) Challenging obesity, diabetes, and addiction: the potential of lorcaserin extended release. Diabetes, Metabolic Syndrome and Obesity 11, pages 469-478.
Read now
Read now
Articles from other publishers (26)
A. K. Khasanova. (2023) Pharmacogenetic Factors of Clozapine-Induced Metabolic Syndrome. Personalized Psychiatry and Neurology 3:2, pages 38-47.
Crossref
Crossref
Yuxin Teng, Amrit Sandhu, Edith J. Liemburg, Elnaz Naderi & Behrooz Z. Alizadeh. (2023) The Progress and Pitfalls of Pharmacogenetics-Based Precision Medicine in Schizophrenia Spectrum Disorders: A Systematic Review and Meta-Analysis. Journal of Personalized Medicine 13:3, pages 471.
Crossref
Crossref
Mujeeb U. Shad. (2023) Seventy Years of Antipsychotic Development: A Critical Review. Biomedicines 11:1, pages 130.
Crossref
Crossref
Olga Płaza, Piotr Gałecki, Agata Orzechowska, Małgorzata Gałecka, Justyna Sobolewska-Nowak & Agata Szulc. (2022) Pharmacogenetics and Schizophrenia—Can Genomics Improve the Treatment with Second-Generation Antipsychotics?. Biomedicines 10:12, pages 3165.
Crossref
Crossref
Sharlene Kaye, Amy Lewandowski, Mitchell Dunne, Julia Bowman & Vicki Archer. (2022) Feasibility of an Intervention Targeting Health through Exergaming as an Alternative to Routine Treatment (FIT HEART): protocol for a non-randomised two-armed pilot study. Pilot and Feasibility Studies 8:1.
Crossref
Crossref
Evangelia Eirini Tsermpini, Tea Terzi, Blanka Kores Plesničar & Vita Dolžan. 2022. Psychiatric Genomics. Psychiatric Genomics
161
188
.
Wei Li, Fengju Liu, Rui Liu, Xinmei Zhou, Guanjun Li & Shifu Xiao. (2021) APOE E4 is associated with hyperlipidemia and obesity in elderly schizophrenic patients. Scientific Reports 11:1.
Crossref
Crossref
Paula Soria-Chacartegui, Gonzalo Villapalos-García, Pablo Zubiaur, Francisco Abad-Santos & Dora Koller. (2021) Genetic Polymorphisms Associated With the Pharmacokinetics, Pharmacodynamics and Adverse Effects of Olanzapine, Aripiprazole and Risperidone. Frontiers in Pharmacology 12.
Crossref
Crossref
Dora Koller, Susana Almenara, Gina Mejía, Miriam Saiz-Rodríguez, Pablo Zubiaur, Manuel Román, Dolores Ochoa, Marcos Navares-Gómez, Elena Santos-Molina, Elena Pintos-Sánchez & Francisco Abad-Santos. (2020) Metabolic Effects of Aripiprazole and Olanzapine Multiple-Dose Treatment in a Randomised Crossover Clinical Trial in Healthy Volunteers: Association with Pharmacogenetics. Advances in Therapy 38:2, pages 1035-1054.
Crossref
Crossref
Kenneth K. C. Man, Shih-Chieh Shao, Yu-Chuan Chang, Mei-Hung Chi, Han Eol Jeong, Swu-Jane Lin, Chien-Chou Su, Ju-Young Shin, Kirstie H. Wong, Ian C. K. Wong, Yea-Huei Kao Yang, Yen-Kuang Yang & Edward Chia-Cheng Lai. (2021) Cardiovascular and metabolic risk of antipsychotics in children and young adults: a multinational self-controlled case series study. Epidemiology and Psychiatric Sciences 30.
Crossref
Crossref
Alfredo B. Cuéllar-Barboza, Susan L. McElroy, Marin Veldic, Balwinder Singh, Simon Kung, Francisco Romo-Nava, Nicolas A. Nunez, Alejandra Cabello-Arreola, Brandon J. Coombes, Miguel Prieto, Hannah K. Betcher, Katherine M. Moore, Stacey J. Winham, Joanna M. Biernacka & Mark A. Frye. (2020) Potential pharmacogenomic targets in bipolar disorder: considerations for current testing and the development of decision support tools to individualize treatment selection. International Journal of Bipolar Disorders 8:1.
Crossref
Crossref
Chao Luo, Junyan Liu, Xu Wang, Xiaoyuan Mao, Honghao Zhou & Zhaoqian Liu. (2019) Pharmacogenetic Correlates of Antipsychotic-Induced Weight Gain in the Chinese Population. Neuroscience Bulletin 35:3, pages 561-580.
Crossref
Crossref
Huqun Li, Shiyong Peng, Shihong Li, Shouqing Liu, Yifan Lv, Ni Yang, Liangyu Yu, Ya-Hui Deng, Zhongjian Zhang, Maosheng Fang, Yunxiang Huo, Ying Chen, Taohua Sun & Weiyong Li. (2019) Chronic olanzapine administration causes metabolic syndrome through inflammatory cytokines in rodent models of insulin resistance. Scientific Reports 9:1.
Crossref
Crossref
Andrea Schmitt, Isabel Maurus, Moritz J. Rossner, Astrid Röh, Moritz Lembeck, Martina von Wilmsdorff, Shun Takahashi, Boris Rauchmann, Daniel Keeser, Alkomiet Hasan, Berend Malchow & Peter Falkai. (2018) Effects of Aerobic Exercise on Metabolic Syndrome, Cardiorespiratory Fitness, and Symptoms in Schizophrenia Include Decreased Mortality. Frontiers in Psychiatry 9.
Crossref
Crossref
Dora Koller, Carmen Belmonte, Rubin Lubomirov, Miriam Saiz-Rodríguez, Pablo Zubiaur, Manuel Román, Dolores Ochoa, Antonio Carcas, Aneta Wojnicz & Francisco Abad-Santos. (2018) Effects of aripiprazole on pupillometric parameters related to pharmacokinetics and pharmacogenetics after single oral administration to healthy subjects. Journal of Psychopharmacology 32:11, pages 1212-1222.
Crossref
Crossref
Tonya Gross & Jeremy Daniel. (2018) Overview of pharmacogenomic testing in clinical practice. Mental Health Clinician 8:5, pages 235-241.
Crossref
Crossref
Justin R. Welden, Zhaiyi Zhang, Marilyn J. Duncan, Marina Falaleeva, Timothy Wells & Stefan Stamm. (2018) The posterior pituitary expresses the serotonin receptor 2C. Neuroscience Letters 684, pages 132-139.
Crossref
Crossref
Clement C. Zai, Arun K. Tiwari, Gwyneth C. Zai, Miriam S. Maes & James L. Kennedy. (2018) New findings in pharmacogenetics of schizophrenia. Current Opinion in Psychiatry 31:3, pages 200-212.
Crossref
Crossref
Saibal Das, Jayanta Kumar Dey, Niranjan Prabhu SS, Sachin David, Aniket Kumar, Deepa Braganza & Margaret Shanthi FX. (2017) Association Between 5-HTR2C -759C/T (rs3813929) and -697G/C (rs518147) Gene Polymorphisms and Risperidone-Induced Insulin Resistance Syndrome in an Indian Population. The Journal of Clinical Pharmacology.
Crossref
Crossref
Junfeng Yao, Xiaoliang Wang, Huangxiang Yan, Xia Cai, Min Wang, Yingying Tu & Changsuo Yang. (2017) Enhanced Expression of Serotonin Receptor 5-Hydroxytryptamine 2C is Associated with Increased Feather Damage in Dongxiang Blue-Shelled Layers. Behavior Genetics 47:3, pages 369-374.
Crossref
Crossref
Jos? Mar?a Rico-Gomis, Antonio Palaz?n-Bru, Irene Triano-Garc?a, Luis Fabi?n Mahecha-Garc?a, Ana Garc?a-Monsalve, Andr?s Navarro-Ruiz, Berta Villagordo-Pe?alver, Jessica Jim?nez-Abril, Alicia Mart?nez-Hortelano & Vicente Francisco Gil-Guill?n. (2016) Association between the HTR2C rs1414334 C/G gene polymorphism and the development of the metabolic syndrome in patients treated with atypical antipsychotics. PeerJ 4, pages e2163.
Crossref
Crossref
Raymond R. MacNeil & Daniel J. Müller. (2016) Genetics of Common Antipsychotic-Induced Adverse Effects. Complex Psychiatry 2:2, pages 61-78.
Crossref
Crossref
Roy H. Perlis. 2016. Genomics, Circuits, and Pathways in Clinical Neuropsychiatry. Genomics, Circuits, and Pathways in Clinical Neuropsychiatry
727
747
.
Malgorzata Maciukiewicz, Venuja Sriretnakumar & Daniel J. Müller. 2016. Genetic Influences on Response to Drug Treatment for Major Psychiatric Disorders. Genetic Influences on Response to Drug Treatment for Major Psychiatric Disorders
21
38
.
O. Godin, M. Leboyer, A. Gaman, B. Aouizerate, F. Berna, L. Brunel, D. Capdevielle, I. Chereau, J.M. Dorey, C. Dubertret, J. Dubreucq, C. Faget, F. Gabayet, Y. Le Strat, P.M. Llorca, D. Misdrahi, R. Rey, R. Richieri, C. Passerieux, A. Schandrin, F. Schürhoff, M. Urbach, P. Vidalhet, N. Girerd, G. Fond, B. Aouizerate, F. Berna, O. Blanc, L. Brunel, E. Bulzacka, D. Capdevielle, I. Chereau-Boudet, G. Chesnoy-Servanin, J.M. Danion, T. D'Amato, A. Deloge, C. Delorme, H. Denizot, M. Depradier, J.M. Dorey, C. Dubertret, J. Dubreucq, C. Faget, C. Fluttaz, G. Fond, S. Fonteneau, F. Gabayet, E. Giraud-Baro, M.C. Hardy-Bayle, D. Lacelle, C. Lançon, H. Laouamri, M. Leboyer, T. Le Gloahec, Y. Le Strat, P.M. Llorca, E. Metairie, D. Misdrahi, I. Offerlin-Meyer, C. Passerieux, P. Peri, S. Pires, C. Portalier, R. Rey, C. Roman, M. Sebilleau, A. Schandrin, F. Schürhoff, A. Tessier, A.M. Tronche, M. Urbach, F. Vaillant, A. Vehier, P. Vidailhet, E. Vilà, H. Yazbek & A. Zinetti-Bertschy. (2015) Metabolic syndrome, abdominal obesity and hyperuricemia in schizophrenia: Results from the FACE-SZ cohort. Schizophrenia Research 168:1-2, pages 388-394.
Crossref
Crossref
Deepan SinghNevil KadakiaAaron Pinkhasov. (2015) Significant Reduction of Aggression with Guanfacine Extended Release in an Adolescent with Prader–Willi Syndrome. Journal of Child and Adolescent Psychopharmacology 25:4, pages 376-377.
Crossref
Crossref